Immtech
Officials from Immtech report details of recent activities
Published in Medical Patent Week, April 29th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Immtech.
Report 1: Immtech Pharmaceuticals, Inc., (IMM) announced that it has completed enrollment in a phase III pivotal trial of its oral drug candidate, pafuramidine maleate (pafuramidine), to treat first-stage patients (those with no evidence of central nervous system involvement) for African trypanosomiasis, also known as African sleeping sickness.
The trial protocol was reviewed and approved by the United States Food & Drug Administration (FDA) under a special...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week
Source: Medical Patent Week (2007-04-29)
More Articles from Medical Patent Week
- Angiography
Data from University of Illinois, Department of Neurosurgery advance knowledge in angiography - Bioscience
New European ARA Infant Formula Patent Strengthens Martek's Intellectual Property Position - Biotechnology
India's biotech industry emerging as world innovator, collaborator, competitor - Capillary Electrophoresis
Transgenomic, Inc. Purchases Certain Assets and Signs Licenses to Supply Customers of SpectruMedix LLC - Diagnostics
Roche to acquire BioVeris to expand its leading ECL immunochemistry business into new market segments - Drug Delivery
Apogee Signs Exclusive License With Georgia Tech for Microneedle Technology - More from this issue of Medical Patent Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
